T 0290/10 (imidazoquinoline amines/3M) du 21.07.2014
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2014:T029010.20140721
- Date de la décision
- 21 juilliet 2014
- Numéro de l'affaire
- T 0290/10
- Requête en révision de
- -
- Numéro de la demande
- 97946484.9
- Langue de la procédure
- Anglais
- Distribution
- Non distribuées (D)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- IMMUNE RESPONSE MODIFIER COMPOUNDS FOR TREATMENT OF TH2 MEDIATED AND RELATED DISEASES
- Nom du demandeur
- MINNESOTA MINING AND MANUFACTURING COMPANY
- Nom de l'opposant
- Telormedix SA
- Chambre
- 3.3.01
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 100(a) 1973European Patent Convention Art 100(b)European Patent Convention Art 100(b) 1973
- Mots-clés
- Request for decision in written proceedings - refused
Submissions and documents alleged to be late filed- filed within the extended time period
Earliest priority claimed - not valid for the claims of all requests
Main request, first and second auxiliary requests: inventive step (no) - obvious application of a known drug for its known purpose
Third auxiliary request: inventive step (yes) - Exergue
- -
- Affaires citantes
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance
with the order to maintain the patent in amended form on the basis of the following documents:
Description pages:
2, 4 to 7 and 9 to 14, filed during oral proceedings on 10 November 2009 before the opposition division, and
3, filed with letter dated 26 April 2010;
Claims:
1 to 5 according to the third auxiliary request, filed with letter dated 26 April 2010.